Stacey D. Finley

According to our database, Stacey D. Finley authored at least 11 papers between 2010 and 2024.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of four.

2024

Flux sampling in genome-scale metabolic modeling of microbial communities.

Patrick E. Gelbach, Handan Cetin, Stacey D. Finley

BMC Bioinform., December, 2024

2023

Calibrating agent-based models to tumor images using representation learning.

Colin G. Cess, Stacey D. Finley

PLoS Comput. Biol., 2023

2022

Kinetic and data-driven modeling of pancreatic β-cell central carbon metabolism and insulin secretion.

Patrick E. Gelbach, Dongqing Zheng, Scott E. Fraser, Kate L. White, Nicholas A. Graham, Stacey D. Finley

PLoS Comput. Biol., October, 2022

Siamese neural networks for a generalized, quantitative comparison of complex model outputs.

Colin G. Cess, Stacey D. Finley

CoRR, 2022

2021

A field guide to cultivating computational biology.

Anne E. Carpenter, Casey S. Greene, Piero Carnici, Benilton S. Carvalho, Michiel de Hoon, Stacey D. Finley, Kim-Anh Lê Cao, Jerry S. H. Lee, Luigi Marchionni, Suzanne Sindi, Fabian J. Theis, Gregory P. Way, Jean Y. H. Yang, Elana J. Fertig

CoRR, 2021

2020

Multi-scale modeling of macrophage - T cell interactions within the tumor microenvironment.

Colin G. Cess, Stacey D. Finley

PLoS Comput. Biol., 2020

2019

Metabolic reprogramming dynamics in tumor spheroids: Insights from a multicellular, multiscale model.

Mahua Roy, Stacey D. Finley

PLoS Comput. Biol., 2019

2018

Mechanistic insight into activation of MAPK signaling by pro-angiogenic factors.

Min Song, Stacey D. Finley

BMC Syst. Biol., 2018

2017

Mechanistic modeling quantifies the influence of tumor growth kinetics on the response to anti-angiogenic treatment.

Thomas D. Gaddy, Qianhui Wu, Alyssa D. Arnheim, Stacey D. Finley

PLoS Comput. Biol., 2017

2011

Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies.

Stacey D. Finley, Marianne O. Engel-Stefanini, Princess I. Imoukhuede, Aleksander S. Popel

BMC Syst. Biol., 2011

2010

In silico feasibility of novel biodegradation pathways for 1, 2, 4-trichlorobenzene.

Stacey D. Finley, Linda J. Broadbelt, Vassily Hatzimanikatis

BMC Syst. Biol., 2010